
    
      Study Intervention Each individual who has completed at least 5 doses hepB vaccine with
      aluminum adjuvant series but is anti-HBs negative will be contacted by EHS staff and invited
      to receive the hepB-CpG two dose series on a 0 and 1 month schedule. Antibody to the surface
      antigen will be measured after the first dose during the visit for the administration of the
      second dose. One month after completion of the series, each immunized individual will have
      another anti-HBs measured.

      Total Number of Subjects Up to 130 individuals will be recruited and enrolled. Study
      Population Healthcare workers who have received at least 5 doses of hepatitis B vaccine with
      aluminum adjuvant and have antiHBs < 10mIU/ml.
    
  